12-14-2018, 04:43 PM
JNJ is already a huge core position for me, so of course I'm sad to see this news. (And for more reasons than just the share price. I'd be especially bummed if they hadn't taken the Tylenol-tampering experience to heart when it comes to full and quick disclosure of problems.)
But I accumulated my shares years ago back when it was in the $60s, and hadn't been planning on buying more any time soon. My plan will be to just sit tight; confident that it will be just fine in the long term. For all of these reasons, I haven't been too focused on its valuation lately. Given that I already own a lot and that I see other more compelling opportunities right now, I'd need to see it come down a lot further before I considered nibbling. Especially since in the near term, if the accusations are accurate, there may be better entry points in the coming months / years.
But I accumulated my shares years ago back when it was in the $60s, and hadn't been planning on buying more any time soon. My plan will be to just sit tight; confident that it will be just fine in the long term. For all of these reasons, I haven't been too focused on its valuation lately. Given that I already own a lot and that I see other more compelling opportunities right now, I'd need to see it come down a lot further before I considered nibbling. Especially since in the near term, if the accusations are accurate, there may be better entry points in the coming months / years.